CTFA/SDA BRIEFING DOCUMENT FOR NDAC MEETING
October 20, 2005

I. Cover Letter / Executive Summary

II. Table of Contents

III. Efficacy

A. Benefits

B. Performance Criteria

IV. Safety

A. Resistance

B. Environmental

V. Appendices

A. Endorsements

B. Letter to FDA Docket 75N-183H, October 6. 2005

VI. Bibliography

A. Benefits

B. Resistance

C. Environmental

AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION